Zobrazeno 1 - 10
of 123
pro vyhledávání: '"Ashish, Bajel"'
Autor:
Ing Soo Tiong, Meaghan Wall, Ashish Bajel, Akash Kalro, Shaun Fleming, Andrew W. Roberts, Nisha Thiagarajah, Chong Chyn Chua, Maya Latimer, David Yeung, Paula Marlton, Amanda Johnston, Anoop Enjeti, Chun Yew Fong, Gavin Cull, Stephen Larsen, Glen Kennedy, Anthony Schwarer, David Kipp, Sundra Ramanathan, Emma Verner, Campbell Tiley, Edward Morris, Uwe Hahn, John Moore, John Taper, Duncan Purtill, Pauline Warburton, William Stevenson, Nicholas Murphy, Peter Tan, Ashanka Beligaswatte, Howard Mutsando, Mark Hertzberg, Jake Shortt, Ferenc Szabo, Karin Dunne, Andrew H. Wei, Australasian Leukaemia and Lymphoma Group (ALLG)
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Despite an increasing desire to use historical cohorts as “synthetic” controls for new drug evaluation, limited data exist regarding the comparability of real-world outcomes to those in clinical trials. Governmental cancer data often lac
Externí odkaz:
https://doaj.org/article/8934e2c0d348469ca8fbc945fd4e9089
Autor:
Michelle Tew, Abby P. Douglas, Jeff Szer, Ashish Bajel, Simon J. Harrison, Shio Yen Tio, Leon J. Worth, Rodney J. Hicks, David Ritchie, Monica A. Slavin, Karin A. Thursky, Kim Dalziel
Publikováno v:
Cancer Imaging, Vol 23, Iss 1, Pp 1-8 (2023)
Abstract Background A recent randomised trial demonstrated [18F]fluorodeoxyglucose positron-emission tomography in combination with low-dose CT (FDG-PET/CT), compared to standard of care computed tomography (CT) imaging, positively impacted antimicro
Externí odkaz:
https://doaj.org/article/9f3f55deb0714951bad950db5f96f42a
Autor:
Shaun Fleming, John Reynolds, Ashish Bajel, Nicola Venn, John Kwan, John Moore, David Yeung, Nalini Pati, Michael Leahy, Sushma Kollipara, Emma Verner, Leanne Berkahn, Rosemary Sutton, Andrew Wei, Matthew Greenwood
Publikováno v:
HemaSphere, Vol 7, p e811479d (2023)
Externí odkaz:
https://doaj.org/article/66d5b696a33040228d793890b514f92f
Autor:
Armin Ghobadi, Ibrahim Aldoss, Shannon Maude, Alan S Wayne, Deepa Bhojwani, Ashish Bajel, Bhagirathbhai Dholaria, Rawan Faramand, Ryan Mattison, Michael Rettig, Ouiam Bakkacha, John Muth, Angela Pannunzio, Brett Ramsey, Eileen Mcnulty, Matthew Cooper, Jan Davidson-Moncada, Kenneth Jacobs, John Dipersio
Publikováno v:
HemaSphere, Vol 7, p e1789302 (2023)
Externí odkaz:
https://doaj.org/article/54e632fd8a1741b4b44130773003313c
Autor:
Anthony Selwyn Stein, Mojca Jongen-Lavrencic, Sylvain Garciaz, Gerwin A Huls, Abhishek Maiti, Nicolas Boissel, Stephane De Botton, Shaun Fleming, C. Michel Zwaan, David C. de Leeuw, Pinkal Desai, Martha Lucia Arellano, David Avigan, Saskia Langemeijer, Kyle Jensen, Timothy Wagenaar, Gu MI, Giovanni Abbadessa, Ashish Bajel
Publikováno v:
HemaSphere, Vol 7, p e66387cd (2023)
Externí odkaz:
https://doaj.org/article/18f46986af184ccba44a04935f01961a
Autor:
Giovanni Marconi, Shukaib Arslan, Shaun Fleming, Antonio Curti, James S Blachly, Giovanni Martinelli, Matteo Giovanni Della Porta, Ashish Bajel, Tim Sauer, Martina Crysandt, Arnaud Pigneux, Marina Konopleva, Yotvat Marmor, Shringi Sharma, Nairouz Elgeioushi, Emily Rowe, Patricia Cheung, Ekaterina Jahn, Jamal Saeh, Raoul Tibes, Fathima Zumla Cader, Nitin Jain
Publikováno v:
HemaSphere, Vol 7, p e80196f1 (2023)
Externí odkaz:
https://doaj.org/article/5275a0432b0c4e3b8794b9932bafe30c
Publikováno v:
HemaSphere, Vol 7, p e96146ca (2023)
Externí odkaz:
https://doaj.org/article/ebaed6d7e6264abc8a932e5cf86e58bd
Publikováno v:
BMC Infectious Diseases, Vol 20, Iss 1, Pp 1-7 (2020)
Abstract Background Vancomycin-resistant enterococcus (VRE) is an important cause of infection in immunocompromised populations. Few studies have described the characteristics of vanB VRE infection. We sought to describe the epidemiology, treatment a
Externí odkaz:
https://doaj.org/article/6c9e7735aaf94d8c9c4793a8fa35f707
Autor:
Jacinta Perram, Duncan Purtill, Ashish Bajel, Jason Butler, Tracey O'Brien, Benjamin Teh, Nicole Gilroy, Phoebe J. Ho, Richard Doocey, Thomas Hills, Travis Perera, Genevieve Douglas, Shanti Ramachandran, Lynette Chee, Judith Trotman, Robert Weinkove, Steven Keogh, Chris Fraser, Tara Cochrane, Anne‐Marie Watson, Peter Diamond, Maya Latimer, Ian Irving, Emily Blyth, Chan Cheah, Theresa Cole, Sam Milliken, Hung Yang, Matthew Greenwood, Peter Bardy, Glen Kennedy, Stephen Larsen, Rachel Conyers, Nada Hamad
Publikováno v:
Internal Medicine Journal. 53:119-125
Autor:
Amer M. Zeidan, Uma Borate, Daniel A. Pollyea, Andrew M. Brunner, Fernando Roncolato, Jacqueline S. Garcia, Robin Filshie, Olatoyosi Odenike, Anne Marie Watson, Ravitharan Krishnadasan, Ashish Bajel, Kiran Naqvi, Jiuhong Zha, Wei‐Han Cheng, Ying Zhou, David Hoffman, Jason G. Harb, Jalaja Potluri, Guillermo Garcia‐Manero
Publikováno v:
American Journal of Hematology. 98:272-281
Patients with relapsed/refractory (R/R) higher-risk myelodysplastic syndromes (MDS) have a dismal median overall survival (OS) after failing hypomethylating agent (HMA) treatment. There is no standard of care for patients after HMA therapy failure; h